Offering lower toxicity and higher accuracy than conventional therapies, this source offers illustrative coverage of this new method to treat tumors associated with brain, breast, lung, and neuroendocrine cancers. Accompanied by a CD offering color images, radiolabeling procedures, and tips on radiopharmceutical administration, this source will offer comprehensive and expert guidance on this burgeoning therapeutic technique.
Edited by:
Marco Chinol, Giovanni Paganelli Imprint: CRC Press Inc Country of Publication: United States Dimensions:
Height: 229mm,
Width: 152mm,
Spine: 23mm
Weight: 640g ISBN:9780824728878 ISBN 10: 0824728874 Pages: 370 Publication Date:08 June 2006 Audience:
Professional and scholarly
,
Professional and scholarly
,
Professional & Vocational
,
Undergraduate
,
Further / Higher Education
Format:Hardback Publisher's Status: Active
THEORY AND PRODUCTION OF PEPTIDES FOR RADIONUCLIDE THERAPY. Peptide Structure and Analysis. Molecular Pharmacology of Receptors. Receptors Distribution and Biochemical Characterization. RADIOLABELING MECHANISMS AND STRATEGIES. Developments of Radiolabeled Peptides. Receptor Targeting for Tumor Therapy with Radiopeptides. New Radionuclides for Peptide Therapy. Pre-Clinical Comparison of Radiolabeled Peptides for Radionuclide Therapy. CLINICAL THERAPEUTIC APPLICATIONS. Phase I Therapeutic Studies. Response to Treatment with Radiolabeled Peptides. Receptor Radionuclide Therapy: From 90Y to 177Lu Labeled Peptides. Therapeutic Potential of Radiolabeled Peptides with Beta and Alpha Emitters. Receptor-Mediated Radionuclide Therapy: The European Institute of Oncology Experience. DOSIMETRIC ASPECTS AND REGULATORY REQUIREMENTS. Radiation Dosimetry in Preparation to Therapy. Dosimetry and Critical Organs. Regulatory Requirements for Therapy Trials. FUTURE PERSPECTIVES. Advances in the Field of Radiopeptides for Therapy
Giovannie Pagnelli Marco Chinol
Reviews for Radionuclide Peptide Cancer Therapy
?Those charged with making further adjustments to a new world and its changed defense needs could profit from this glance at recent history.?-Foreign Affairs